Repurposed drugs & anti-parasitics
Old drugs studied for new uses, with a cancer section on ivermectin, fenbendazole and mebendazole.
Don't stop, replace, or delay any treatment without talking to your doctor.
General
Cancer: ivermectin, fenbendazole & mebendazole
Don't stop, replace, or delay any cancer treatment without talking to your oncologist. Fenbendazole is a veterinary drug. It is not approved for use in humans.
Repurposed drugs & anti-parasitics · 2023-06-01 · Paul Marik MD, Independent Medical Alliance (formerly FLCCC), 'Cancer Care' / repurposed-drugs guide, updated 2026
Marik reviews lab, animal and case evidence and proposes ivermectin, mebendazole and others as adjuncts.…
Repurposed drugs & anti-parasitics · 2021-02-10 · Chiang, Syed, Wright, Montgomery, Srinivas (Stanford / Univ. of Washington), Clinical Oncology Case Reports 4:2, 2021
The authors describe three patients "who demonstrated complete response after receiving FBZ therapy as a single or supplementary chemotherapeutic agent"; two had progressed "despite multiple lines of therapy." "No side e…
Repurposed drugs & anti-parasitics · 2020-01-01 · Abughanimeh, Evans, Kallam (Univ. of Nebraska Medical Center), Austin Hematology, 2020
Repeat CT showed "smaller mediastinal lymph nodes," and later PET/CT "revealed interval improvement in his disease with no new lesion seen."…
Repurposed drugs & anti-parasitics · 2018-01-01 · Jane McLelland, book 'How to Starve Cancer' and website
McLelland describes her own long-term survival and the protocol she credits.…
Repurposed drugs & anti-parasitics · 2016-08-01 · Joe Tippens, personal blog "Get Busy Living" (mycancerstory.rocks)
Tippens reports a clear PET scan after about three months and attributes his recovery to the regimen.…
Repurposed drugs & anti-parasitics · 2014-07-10 · Pantziarka et al. (Anticancer Fund / GlobalCures), ecancermedicalscience, 2014
Mebendazole "has anti-cancer properties that have been elucidated in a broad range of pre-clinical studies," and "there are also two case reports of anti-cancer activity in humans." The authors call it a "low-cost agent"…
Paper Trail Health summarizes published studies, case reports, court filings and journalism for general information. It is not medical, legal or investment advice. Summaries quote the sources; a source's statements are its authors', not findings of this site. Don't stop, replace, or delay treatment without your doctor. Always read the linked original. See
Standards & corrections and
Disclaimer.